Business Wire · TAK · October 14, 2026

Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1

Get the app for more

Explore stock news, insights and company research.